Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)

Main Article Content

Diamant Thaci
Alice Gottlieb
Kristian Reich
Jerry Bagel
Daniel Burge
Luke Peterson
Janice Drew
Catherine Arendt
Jolanta Weglowska

Keywords

psoriasis, certolizumab, randomized trial, multicenter

Abstract

Abstract Not Available

 

Disclosure: Study supported by Dermira.